Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in mice
- PMID: 8348566
- PMCID: PMC11038132
- DOI: 10.1007/BF01518522
Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in mice
Abstract
Physical and immunogenic properties of reconstituted membranes designed for the presentation of tumour-associated antigens (TAA) to the immune system are described. Proteins and lipids of crude membranes of SL2 murine lymphosarcoma cells were partially solubilized with octylglucoside. Reconstituted membranes, consisting mainly of unilamellar vesicles with a diameter of 0.03-0.15 microns, were formed by detergent removal and were purified by floatation in a discontinuous sucrose gradient to remove non-lipid-bound protein. Subcutaneous immunization of syngeneic mice with reconstituted membranes or with purified reconstituted membranes induced protection against an intraperitoneal challenge with 10(3) viable SL2 cells. Reconstituted membranes were more immunogenic than crude membranes in immunoprotection experiments when compared on the basis of protein dose. Detergent removal was required to obtain an immunogenic presentation form of SL2 membrane antigens and to avoid toxicity associated with the detergent. Reconstitution of SL2 membranes in the presence of exogenous phospholipid slightly increased the fraction of protein that associated with the reconstituted membranes. However, the immunogenicity of the solubilized membrane TAA was not significantly affected by the presence of exogenous phospholipid. The reconstitution procedure described may be useful in identifying membrane factors required for the induction of immune responses against TAA. The versatility of the system may be employed to develop safe alternatives for whole-cell vaccines.
Similar articles
-
Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells.Cancer Immunol Immunother. 1992;34(4):233-40. doi: 10.1007/BF01741791. Cancer Immunol Immunother. 1992. PMID: 1537056 Free PMC article.
-
Effect of immunomodulators on specific tumor immunity induced by liposome-encapsulated tumor-associated antigens.Int J Cancer. 1994 Mar 1;56(5):721-6. doi: 10.1002/ijc.2910560518. Int J Cancer. 1994. PMID: 8314349
-
Estimation in sera by radioimmunoassay of a specific membrane antigen associated with a murine lymphoma.Br J Cancer. 1976 Feb;33(2):144-53. doi: 10.1038/bjc.1976.19. Br J Cancer. 1976. PMID: 1259913 Free PMC article.
-
Carrier and adjuvant properties of liposome-borne tumor-specific antigens.Cancer Immunol Immunother. 1984;17(2):135-41. doi: 10.1007/BF00200050. Cancer Immunol Immunother. 1984. PMID: 6565518 Free PMC article.
-
Targeting dendritic cells with antigen-containing liposomes: antitumour immunity.Expert Opin Biol Ther. 2004 Nov;4(11):1735-47. doi: 10.1517/14712598.4.11.1735. Expert Opin Biol Ther. 2004. PMID: 15500402 Review.
References
-
- Balcarova J, Helenius A, Simons K. Antibody response to spike protein vaccines prepared from Semlike Forest virus. J Gen Virol. 1981;53:85. - PubMed
-
- Balch CM, Riley LB, Bae YJ, Salmeron MA, Platsoucas CD, Von Eschenbach A, Itoh K. Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg. 1990;125:200. - PubMed
-
- Bergers JJ, Storm G, Den Otter W. Liposome technology, vol II. 2nd edn. Boca Raton, Fla.: CRC Press; 1993. Liposomes as vehicles for the presentation of tumor-associated antigens; p. 141.
-
- Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources